During female mammal reproductive tract development, epithelial cells of the lower Müllerian duct are 4 committed to become stratified squamous epithelium of vagina and ectocervix, when the expression 5 of ΔNp63 transcription factor is induced by mesenchymal cells. The absence of ΔNp63 expression 6 leads to adenosis, the putative precursor of vaginal adenocarcinoma. Our previous studies with 7 genetically engineered mouse models have established that fibroblast growth factor (FGF)/mitogen-8 activated protein kinase (MAPK), bone morphogenetic protein (BMP)/SMAD, and activin A/runt 9 related transcription factor 1 (RUNX1) signaling pathways are independently required for ΔNp63 10 expression in Müllerian duct epithelium (MDE). Here we report that sine oculis homeobox homolog 1 11 (SIX1) plays a critical role in the activation of ΔNp63 locus in MDE as a downstream transcription 12 factor of mesenchymal signals. In mouse developing reproductive tract, SIX1 expression was 13 restricted to MDE of the future cervix and vagina. SIX1 expression was totally absent in SMAD4 null 14 MDE and was reduced in RUNX1 null and FGFR2 null MDE, indicating that SIX1 is under the control 15 of vaginal mesenchymal factors, BMP4, activin A and FGF7/10. Furthermore, Six1, Runx1 and 16 Smad4 gene-dose-dependently activated ΔNp63 expression in MDE within vaginal fornix. Using a 17 mouse model of diethylstilbestrol (DES)-associated vaginal adenosis, we found DES action through 18 epithelial estrogen receptor α (ESR1) down-regulates SIX1 and RUNX1 in MDE within the vaginal 19 fornix. This study establishes that the vaginal/ectocervical cell fate of MDE is regulated by a 20 collaboration of multiple transcription factors including SMAD4, SIX1 and RUNX1, and the down-21 regulation of these key transcription factors leads to vaginal adenosis. 22 23
INTRODUCTION 40
In mammals, the majority of female reproductive tract (FRT) develops from the Müllerian ducts (MDs) 41
[1-3]. During embryogenesis, the MDs undergo a dynamic transformation from simple tubes 42 consisting of homogeneous epithelium and mesenchyme into distinct organs, namely the oviduct, 43 uterus, cervix and vagina [2, 4] . Classic tissue recombination studies have established that organ-44 specific mesenchyme induces the differentiation of MD epithelium (MDE) into epithelia with unique 45 morphology and functions [5] [6] [7] . In the lower MD, epithelial cells are committed to become stratified 46 squamous epithelium of ectocervix and vagina (together referred to as "vagina" hereafter), as the 47 expression of ΔNp63 transcription factor is induced by vaginal mesenchyme [8] [9] [10] . In MDE of the 48 developing vagina, the expression of ΔNp63 is activated by mesenchymal paracrine factors: bone 49 morphogenetic protein (BMP) 4, activin A (ActA) and fibroblast growth factor (FGF) 7 or 10 [11, 12] . 50 SMAD4 is essential for the activation of ΔNp63 in MDE, and this transcription factor binds on the 5' 51 sequence adjacent to the transcription start site (TSS) of ΔNp63 in future vaginal epithelium (VgE) but 52 not in future uterine epithelium (UtE) [12] . This SMAD-dependent activation of the ΔNp63 locus 53 requires runt-related transcription factor 1 (RUNX1), a co-transcription factor of SMADs. In MDE, the 54 expression of RUNX1 is activated by ActA through a SMAD-independent mechanism [11] . In addition, 55 activation of the mitogen-activated protein kinase (MAPK) pathway by FGF7/10-FGF receptor 2 IIIb 56 (FGFR2IIIb) is essential for the activation of ΔNp63 locus in MDE [11] . BMP4-SMADs, ActA-RUNX1 57 and FGF7/10-MAPK pathways are independently required for the vaginal cell fate commitment of 58 MDE, as inactivation of Smad4, Runx1 or Fgfr2 in MDE results in uterine epithelial differentiation of 59 MDE within the vagina, which is a congenital epithelial lesion called vaginal adenosis [11, 12] . 60
Nevertheless, once the ΔNp63 locus is activated in MDE, the transcriptional activity of the ΔNp63 61 locus is cell-autonomously maintained by ΔNp63 protein itself [12] . Hence, the identity of VgE is 62 maintained independent of mesenchymal factors [7, 8] . 63
In this study, we investigated the role of sine oculis homeobox homolog 1 (SIX1) in the cell fate 64 commitment of VgE. In mammals, SIX1 and other five SIX genes (SIX2-6) synergistically regulate the 5 developmental process in multiple organs, including inner ear, salivary gland, kidney, lung, and 66 trachea [13, 14] . In mouse FRTs, Six1 is enriched in the vagina compared to the uterus [12, 15] . 67
However, its biological function in FRT remains unclear. Our current mouse genetic study reveals that 68 SIX1 co-operates with RUNX1 and SMAD4 in the activation of the ΔNp63 locus in MDE as a 69 downstream transcription factor of BMP4, ActA and FGF7/10 in MDE. The etiology of vaginal 70 adenosis, the putative precursor to vaginal adenocarcinoma (VAC) is commonly associated with 71 intrauterine exposure to estrogenic compounds, including diethylstilbestrol (DES) [16] . Our previous 72 studies established that DES induces vaginal adenosis through inhibition of ΔNp63 expression in 73 MDE. Our current study provides evidence that DES blocks the activation of ΔNp63 locus in future 74
VgE by repressing SIX1 and RUNX1 through epithelial estrogen receptor α (ESR1). Such discoveries 75 from our models may contribute to the prevention and therapeutic treatment of VACs, the etiology of 76 which is currently unknown. 77
78

RESULTS
79
Expression patterns of SIX1 in neonatal FRTs. 80
ΔNp63α is the dominant isoform of the transcription factor encoded by Trp63/TP63 in mouse/human 81 VgE [10, 12]. To identify molecules that control epithelial cell fate in the lower FRT, we conducted 82 microarray analysis of neonatal vagina and uterus from MDE-specific conditional KO (cKO) and 83 conditional heterozygous (cHet, control) mice of Trp63 [12]. In the analysis, Six1 was more enriched 84 in vaginae than uteri (1.02 Log2 fold-change, p = 0.0013) at postnatal day 2 (PD2), when induction of 85
ΔNp63 expression is in progress in the vagina ( Fig 1A) . The expression level of Six1 transcripts was 86 not significantly different between Trp63 cKO and cHET mice (Log2 cHET/cKO = -0.176, p = 0.23) 87 (GSE44697) [12] , indicating that SIX1 is not the target of TRP63. Immunoblotting confirmed the 88 results of microarray: SIX1 protein was detected in vaginae but not in uteri and ovaries from PD2 89 C57BL/6J mice ( Fig 1B) . 90
6
Similarly to the expression of ΔNp63 in developing vagina, SIX1 expression progressed from posterior 91 to anterior. At birth, SIX1 was expressed in the MDE of the lower vagina but not in the upper vagina 92 and cervix, where RUNX1 already highlighted the future VgE ( Fig 1C) . By PD2, SIX1 expression 93 extended to the cervix ( Fig 1D) , thus SIX1 and RUNX1 were co-expressed in the future VgE. There 94 were substantial differences in the expression patterns of SIX1 and RUNX1 in neonatal FRTs. RUNX1 95 was concentrated in the MDE in the cervical canal and the upper-portion of vagina, and the 96 expression was reduced in the posterior portion from the outer-wall of the fornix (Fig 1D, outer-wall of 97 fornix is marked with white dotted-line), whereas SIX1 was expressed at a similar level in both inner 98 and outer walls of the fornix ( Fig 1D) . In addition, RUNX1 in MDE was down-regulated upon 99 expression of ΔNp63 ( Fig 1E, expression of SIX1 is independent of ΔNp63 (Fig 2A) . In contrast, expression of SIX was SMAD4 105 dependent: Smad4 cKO mice [12] completely lacked the expression of SIX1 in the entire MDE as 106 assessed at PD2 (n = 5) ( Fig 2B) . 107
The absence of SIX1 in Smad4 cKO mice suggested that SIX1 is the downstream transcription factor 108 of BMP4-SMAD pathway. Therefore, Bmp4 was knocked out in vaginal mesenchyme utilizing 109 Twist2 Cre [17] , and the effect on the expression of SIX1 in the lower Müllerian duct was assessed. 110
Mesenchyme-specific Bmp4 conditional KO (ms-cKO) was embryonic lethal. Hence, we collected 111 pelvic organs from Bmp4 conditional ms-cKO and ms-cHET mice at embryonic day 15.5, when most 112
Bmp4 ms-cKO embryos exhibited normal growth. At embryonic day 15.5 ( Fig 2C) , RUNX1 expression 113 highlighted the anterior portion of MDE in both Bmp4 ms-cKO and ms-cHET mice. On the other hand, 114 SIX1 expression in MDE was low and mostly cytoplasmic at this age. Nevertheless, the SIX1 signal in 115 MDE was higher in Bmp4 ms-cHET mice compared to Bmp4 ms-cKO mice (n=3 each, Fig 2D) , 7 suggesting that BMP4 is a factor regulating SIX1 expression in FRT. However, the effect of loss of 117 BMP4 on SIX1 expression was not comparable to the loss of SMAD4. This might be due to 118 incomplete deletion of Bmp4 or compensation by other BMP family members, as phosphorylation of 119 SMAD1/5/9 was still present in the MDE of Bmp4 cKO mice ( Fig 2C) . Accordingly, we tested the effect of BMP4, ActA and FGF10 on SIX1 expression in uterine organ 130 culture assay. ActA and FGF10 had minimal to no effect on SIX1 expression in the epithelium of 131 uterine explants (not shown). BMP4 slightly increased SIX1 in UtE, but the nuclear expression was 132 mostly absent ( Fig 3F) . Even when all 3 factors were combined, nuclear SIX1 expression was 133 detected only in portions of UtE showing ΔNp63 expression, suggesting that SIX1 promotes ΔNp63 134 expression in MDE. In the uterine organ culture, growth factors in the medium must diffuse through 135 the mesenchymal layers to act on UtE. Diffusion of FGF10 within connective tissues is limited 136 because of its high affinity to heparan sulfate [18] . Accordingly, we replaced FGF10 with the 137 expression of MAP2K1 DD , which itself did not induce expression of ΔNp63, RUNX1 and SIX1 [11] . where the expression of RUNX1 is reduced ( Fig 1D) . Meanwhile, RUNX1 expression in the vaginal 157 fornix was not affected in Six1 cKO mice ( Fig 4A) . Hence, we generated the compound conditional Six1;Smad4 double cHET mice expressed ΔNp63 throughout the vagina at PD4. However, the 174 density of basal cells on the outer-wall of the fornix was reduced ( Fig 5) . The synergy between Six1 175
and Smad4 alleles became more prominent when an additional Six1 allele was inactivated ( Fig 5) . Previously, we demonstrated that down-regulation of RUNX1 is involved in the pathogenesis of DES-219 associated vaginal adenosis. DES down-regulated RUNX1 in MDE of vaginal fornix within 24 hours 220 ( Fig 6A) . However, the effect of 24-hour DES-treatment was more prominent on SIX1 than RUNX1: 221
Nuclear expression of SIX1 disappeared from the MDE in the vaginal fornix and the cervical canal of 222 DES-treated mice (Fig 6A and 6B) . DES slightly reduced pSMAD1/5/9 in the vaginal mesenchyme, 223 while DES had no evident effect on the epithelial pSMAD1/5/9 ( Fig 6C) . In contrast, DES-treatment 224 consistently increased MAPK1/3 activity in vaginal epithelium and mesenchyme ( Fig 6C) . Hence, the 225 down-regulation of SIX1 was not likely due to the repression of BMP4 or FGF7/10 activity in MDE by 226
DES. 227
Our previous tissue recombination study has established that DES blocks expression of ΔNp63 in 228 MDE through estrogen receptor α (ESR1) within epithelial cells [4, 8] . The expression patterns of SIX1, 229 RUNX1 and ΔNp63 in the fornix of Esr1 cKO mice were indistinguishable from these in wild type mice 230 at PD3 ( Fig 7A) . In agreement with the tissue recombination study, DES did not block the induction of 231
ΔNp63 in the VgE when Esr1 was deleted in MDE by Wnt7a-Cre (Esr1 cKO mice) ( Fig 7B) . Moreover, 232 DES exposure promoted the expression of ΔNp63 in VgE in Esr1 cKO mice (Fig 7B) , forming a 233 continuous layer of ΔNp63-positive cells by PD3, ≥ 1 day earlier than normal development. Therefore, 234 ESR1 in epithelium and mesenchyme has the opposite effect on the induction of ΔNp63 (S3 Fig). In 235 fact, DES-treatment induced RUNX1 and SIX1 in the UtE of Esr1 cKO mice by PD3 (not shown). 236
DES-ESR1 activity attenuates the expression of SIX1 and RUNX1 in MDE cell-autonomously, as the 237
expression of SIX1 and RUNX1 was maintained in the vaginal fornices of Esr1 cKO mice ( Fig 7C) . In this study, we identified SIX1 as a key transcription factor that mediates the mesenchymal signals 258 in the activation of ΔNp63 locus during vaginal cell fate commitment of MDE. Subsequently, we 259 propose that vaginal mesenchymal factors induce MDE to commit to vaginal epithelial cell fate by 260 activating ΔNp63 locus through cooperation of multiple enhancer elements, which are activated by 261
SMADs, RUNX1 and/or SIX1 (Fig. 8 ). An enhancer is a genomic region of few hundred base pairs 262 that contains clustered binding-sites for multiple transcription factors. Although many transcription 263 
Mouse models 325
All animal procedures were approved by the Animal Care and Use Committee in the Ohio State 326
University. The mouse strains carrying the following alleles were utilized: Jackson Laboratory (Bar Harbor, ME). MDE-specific conditional knockout (cKO) and conditional 333 heterozygous (cHET) mice were generated by crossing lines carrying floxed alleles with Wnt7a-Cre 334 mice, except for Trp63 flox mice, which were crossed with Pax2-Cre. Twist2 Cre mice were used for 335 mesenchyme-specific deletion of Bmp4. The day of birth was count as PD1. 336 337
Neonatal DES treatment 338
A ~40 µg DES slow-release pellet was prepared as previously described [12] . The ~0.04 mg/mm DES 339 filled tubing was cut into 1 mm length and subcutaneously injected into newborn mice using a 19 340 gauge trocar. The methods for the quantitative analysis on the squamous transformation of MDE [12] and the IF 369 signal [50] were previously described. We adapted these methods with some modifications. The 370 length of epithelium at the basal lamina was measured in the outer-wall of vaginal fornix in at least 2 371 sections per animal in TRP63 immunostained sections. The proportion of epithelium with ΔNp63-372 psotive basal layer was calculated by "length of epithelial basement membrane associated with 373 TRP63-positive cells" ÷ "total epithelial basement membrane length" x 100, for each mouse. 374
Basal cell density in the outer and inner fornix walls was calculated by number of TRP63-positive 375 pixels per epithelial basement membrane length. In tissue sections of vaginal fornices stained for 376 TRP63, epithelial areas were manually selected, and the pixels positive for TRP63 signal within the 377 epithelium were selected by adjusting the lower threshold for positivity to exclude background noise. 378
Epithelial basement membrane was manually marked on the IF images, and the p63-positive area 379 and the basement membrane length were measured utilizing Image J (NIH, Bethesda, MD). Analysis 380 was performed on ≥ 4 fornice from ≥ 3 mice per group. The value in each fornix was considered as a 381 single measurement. Statistical significance was analyzed by One-way ANOVA with post-hoc 382
Tukey's HSD Test. 383
384
SIX1 IF analysis 385
Quantitative IF assay was performed as previously described with modifications [50]. Tissue sections 386 for an analysis were stained together, and images were captured at the same time under the identical 387 conditions. Images of ≥ 4 tissue sections from n≥ 3 independent animals were analyzed for each 388 group. Epithelial areas were manually selected, and the signal intensity per pixel within the epithelial 389 area was measured by Image J. In all experiments, approximately equivalent areas were analyzed in 390 each sample, and there was no significant intragroup difference in the average signal intensity. Thus, 391 all samples in each group were plotted together, and the distributions of signals were compared 392 between groups by the Mann-Whitney U test with continuity correction. 393
Immunoblot analysis 395
Ovaries, uteri and vaginae from PD2 mice (5-6 mice per blot) were homogenized with a minipestle in 396 ice-cold lysis buffer containing protease (cOmplete Protease Inhibitor Cocktail,Roche) and 397 phosphatase (phoSTOP, Roche) inhibitors and loaded onto NuPAGE 4-12% Bis-Tris precast SDS-398 PAGE gel. Proteins were transferred to a PVDF membrane (Millipore Sigma, St. Louis, MO, USA). 399
The membrane was incubated with anti-RUNX1 antibody (1: 2000, Epitomics), anti-SIX1 antibody 400
(1:1,000, Millipore Sigma) and GAPDH (1: 2000, G8795, Millipore Sigma) in the OdysseyR Blocking 
